Neil Miller has been named chief executive of Auspherix Ltd, the anti-infectives company, having previously been chief scientific officer. Simultaneously the company announced the appointment of Richard Rutter as the new CSO and Paul King as head of chemistry. Dr Miller has been CSO for the past 12 months where he has been responsible for the company’s antibiotic R&D programmes. Previously, he was an executive at GlaxoSmithKline Plc.
Auspherix announced the appointments on 17 November 2016.
Copyright 2016 Evernow Publishing Ltd